APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rabies Vaccine

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Selected research

Market Structure

Global Rabies Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025184 pages

Choose your research edition.

Industry ResearchRabies Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Rabies Vaccine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Rabies Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rabies Vaccine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Rabies Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Global Rabies Vaccine key players include Chengda, Changsheng, Prcmise, VACN, etc. Global top four manufacturers hold a share about 70%.

China is the largest market, with a share about 85%, followed by Europe, and North America, both have a share over 10 percent.

Read the full market overview

In terms of product, Vero Cell Rabies Vaccine is the largest segment, with a share over 75%. And in terms of application, the largest application is Post-exposure Prophylaxis, followed by Pre-exposure Prophylaxis.

This report provides an overview of the global Rabies Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rabies Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rabies Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rabies Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Rabies Vaccine Segment by Company

GSK (Novartis)

Sanofi-Pasteur

Chengda

Yisheng

Prcmise

VACN

Changsheng

BCHT

Hissen

Rabies Vaccine Segment by Type

Vero Cell Rabies Vaccine

BHK

Chick Embryo Cell Rabies Vaccine

Others

Rabies Vaccine Segment by Application

Pre-exposure Prophylaxis

Post-exposure Prophylaxis

Rabies Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rabies Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rabies Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rabies Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rabies Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Rabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Rabies Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Rabies Vaccine Industry Trends Table 2. Rabies Vaccine Industry Drivers Table 3. Rabies Vaccine Industry Opportunities and Challenges Table 4. Rabies Vaccine Industry Restraints Table 5. Global Rabies Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Rabies Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Rabies Vaccine Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Rabies Vaccine Sales Market Share by Manufacturers Table 9. Global Rabies Vaccine Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Rabies Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Rabies Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Rabies Vaccine Manufacturers, Product Type & Application Table 13. Global Rabies Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Rabies Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vero Cell Rabies Vaccine Table 17. Major Manufacturers of BHK Table 18. Major Manufacturers of Chick Embryo Cell Rabies Vaccine Table 19. Major Manufacturers of Others Table 20. Global Rabies Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Rabies Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Global Rabies Vaccine Sales by Type (2027-2032) & (K Units) Table 23. Global Rabies Vaccine Sales Market Share by Type (2021-2026) Table 24. Global Rabies Vaccine Sales Market Share by Type (2027-2032) Table 25. Global Rabies Vaccine Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Rabies Vaccine Revenue by Type (2021-2026) & (K Units) Table 27. Global Rabies Vaccine Revenue by Type (2027-2032) & (K Units) Table 28. Global Rabies Vaccine Revenue Market Share by Type (2021-2026) Table 29. Global Rabies Vaccine Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pre-exposure Prophylaxis Table 31. Major Manufacturers of Post-exposure Prophylaxis Table 32. Global Rabies Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Rabies Vaccine Sales by Application (2021-2026) & (K Units) Table 34. Global Rabies Vaccine Sales by Application (2027-2032) & (K Units) Table 35. Global Rabies Vaccine Sales Market Share by Application (2021-2026) Table 36. Global Rabies Vaccine Sales Market Share by Application (2027-2032) Table 37. Global Rabies Vaccine Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Rabies Vaccine Revenue by Application (2021-2026) & (K Units) Table 39. Global Rabies Vaccine Revenue by Application (2027-2032) & (K Units) Table 40. Global Rabies Vaccine Revenue Market Share by Application (2021-2026) Table 41. Global Rabies Vaccine Revenue Market Share by Application (2027-2032) Table 42. Global Rabies Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Rabies Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Rabies Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Rabies Vaccine Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Rabies Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 49. North America Rabies Vaccine Sales by Country (2027-2032) & (K Units) Table 50. Europe Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 52. Europe Rabies Vaccine Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Rabies Vaccine Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Rabies Vaccine Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Rabies Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Rabies Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Rabies Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Rabies Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Rabies Vaccine Revenue Market Share by Region (2021-2026) Table 63. Global Rabies Vaccine Revenue Market Share by Region (2027-2032) Table 64. GSK (Novartis) Company Information Table 65. GSK (Novartis) Business Overview Table 66. GSK (Novartis) Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GSK (Novartis) Rabies Vaccine Product Portfolio Table 68. GSK (Novartis) Recent Development Table 69. Sanofi-Pasteur Company Information Table 70. Sanofi-Pasteur Business Overview Table 71. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sanofi-Pasteur Rabies Vaccine Product Portfolio Table 73. Sanofi-Pasteur Recent Development Table 74. Chengda Company Information Table 75. Chengda Business Overview Table 76. Chengda Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Chengda Rabies Vaccine Product Portfolio Table 78. Chengda Recent Development Table 79. Yisheng Company Information Table 80. Yisheng Business Overview Table 81. Yisheng Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Yisheng Rabies Vaccine Product Portfolio Table 83. Yisheng Recent Development Table 84. Prcmise Company Information Table 85. Prcmise Business Overview Table 86. Prcmise Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Prcmise Rabies Vaccine Product Portfolio Table 88. Prcmise Recent Development Table 89. VACN Company Information Table 90. VACN Business Overview Table 91. VACN Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. VACN Rabies Vaccine Product Portfolio Table 93. VACN Recent Development Table 94. Changsheng Company Information Table 95. Changsheng Business Overview Table 96. Changsheng Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Changsheng Rabies Vaccine Product Portfolio Table 98. Changsheng Recent Development Table 99. BCHT Company Information Table 100. BCHT Business Overview Table 101. BCHT Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. BCHT Rabies Vaccine Product Portfolio Table 103. BCHT Recent Development Table 104. Hissen Company Information Table 105. Hissen Business Overview Table 106. Hissen Rabies Vaccine Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Hissen Rabies Vaccine Product Portfolio Table 108. Hissen Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Rabies Vaccine Distributors List Table 112. Rabies Vaccine Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Rabies Vaccine Product Image Figure 2. Global Rabies Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rabies Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Rabies Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Rabies Vaccine Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Rabies Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vero Cell Rabies Vaccine Image Figure 9. BHK Image Figure 10. Chick Embryo Cell Rabies Vaccine Image Figure 11. Others Image Figure 12. Global Rabies Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Rabies Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Rabies Vaccine Sales Market Share by Type (2021-2032) Figure 15. Global Rabies Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Rabies Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Rabies Vaccine Revenue Market Share by Type (2021-2032) Figure 18. Pre-exposure Prophylaxis Image Figure 19. Post-exposure Prophylaxis Image Figure 20. Global Rabies Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Rabies Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Rabies Vaccine Sales Market Share by Application (2021-2032) Figure 23. Global Rabies Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Rabies Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Rabies Vaccine Revenue Market Share by Application (2021-2032) Figure 26. North America Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Rabies Vaccine Sales Market Share by Country (2021-2032) Figure 28. U.S. Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Rabies Vaccine Sales Market Share by Country (2021-2032) Figure 33. Germany Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Rabies Vaccine Sales Market Share by Country (2021-2032) Figure 40. China Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Rabies Vaccine Sales Market Share by Country (2021-2032) Figure 48. Brazil Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Rabies Vaccine Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Rabies Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Rabies Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Rabies Vaccine Revenue (2021-2032) & (US$ Million) Figure 59. North America Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Rabies Vaccine Revenue (2021-2032) & (US$ Million) Figure 61. Europe Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Rabies Vaccine Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Rabies Vaccine Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Rabies Vaccine Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Rabies Vaccine Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Vero Cell Rabies Vaccine
  • BHK
  • Chick Embryo Cell Rabies Vaccine
  • Others
Applications
  • Pre-exposure Prophylaxis
  • Post-exposure Prophylaxis
Companies covered
  • GSK (Novartis)
  • Sanofi-Pasteur
  • Chengda
  • Yisheng
  • Prcmise
  • VACN
  • Changsheng
  • BCHT
  • Hissen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rabies Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rabies Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Rabies Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Rabies Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Rabies Vaccine Market Dynamics
  1. 2.1 Rabies Vaccine Industry Trends
  2. 2.2 Rabies Vaccine Industry Drivers
  3. 2.3 Rabies Vaccine Industry Opportunities and Challenges
  4. 2.4 Rabies Vaccine Industry Restraints
3 Rabies Vaccine Market by Manufacturers
  1. 3.1 Global Rabies Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Rabies Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Rabies Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Rabies Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Rabies Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Rabies Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Rabies Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Rabies Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Rabies Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Rabies Vaccine Tier 1, Tier 2, and Tier 3
4 Rabies Vaccine Market by Type
  1. 4.1 Rabies Vaccine Type Introduction
  2. 4.1.1 Vero Cell Rabies Vaccine
  3. 4.1.2 BHK
  4. 4.1.3 Chick Embryo Cell Rabies Vaccine
  5. 4.1.4 Others
  6. 4.2 Global Rabies Vaccine Sales by Type
  7. 4.2.1 Global Rabies Vaccine Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Rabies Vaccine Sales by Type (2021-2032)
  9. 4.2.3 Global Rabies Vaccine Sales Market Share by Type (2021-2032)
  10. 4.3 Global Rabies Vaccine Revenue by Type
  11. 4.3.1 Global Rabies Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Rabies Vaccine Revenue by Type (2021-2032)
  13. 4.3.3 Global Rabies Vaccine Revenue Market Share by Type (2021-2032)
5 Rabies Vaccine Market by Application
  1. 5.1 Rabies Vaccine Application Introduction
  2. 5.1.1 Pre-exposure Prophylaxis
  3. 5.1.2 Post-exposure Prophylaxis
  4. 5.2 Global Rabies Vaccine Sales by Application
  5. 5.2.1 Global Rabies Vaccine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Rabies Vaccine Sales by Application (2021-2032)
  7. 5.2.3 Global Rabies Vaccine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Rabies Vaccine Revenue by Application
  9. 5.3.1 Global Rabies Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Rabies Vaccine Revenue by Application (2021-2032)
  11. 5.3.3 Global Rabies Vaccine Revenue Market Share by Application (2021-2032)
6 Global Rabies Vaccine Sales by Region
  1. 6.1 Global Rabies Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rabies Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Rabies Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Rabies Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Rabies Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Rabies Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Rabies Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Rabies Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Rabies Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Rabies Vaccine Revenue by Region
  1. 7.1 Global Rabies Vaccine Revenue by Region
  2. 7.1.1 Global Rabies Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Rabies Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Rabies Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Rabies Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Rabies Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Rabies Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Rabies Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Rabies Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Rabies Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK (Novartis)
  2. 8.1.1 GSK (Novartis) Company Information
  3. 8.1.2 GSK (Novartis) Business Overview
  4. 8.1.3 GSK (Novartis) Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK (Novartis) Rabies Vaccine Product Portfolio
  6. 8.1.5 GSK (Novartis) Recent Developments
  7. 8.2 Sanofi-Pasteur
  8. 8.2.1 Sanofi-Pasteur Company Information
  9. 8.2.2 Sanofi-Pasteur Business Overview
  10. 8.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi-Pasteur Rabies Vaccine Product Portfolio
  12. 8.2.5 Sanofi-Pasteur Recent Developments
  13. 8.3 Chengda
  14. 8.3.1 Chengda Company Information
  15. 8.3.2 Chengda Business Overview
  16. 8.3.3 Chengda Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chengda Rabies Vaccine Product Portfolio
  18. 8.3.5 Chengda Recent Developments
  19. 8.4 Yisheng
  20. 8.4.1 Yisheng Company Information
  21. 8.4.2 Yisheng Business Overview
  22. 8.4.3 Yisheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yisheng Rabies Vaccine Product Portfolio
  24. 8.4.5 Yisheng Recent Developments
  25. 8.5 Prcmise
  26. 8.5.1 Prcmise Company Information
  27. 8.5.2 Prcmise Business Overview
  28. 8.5.3 Prcmise Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Prcmise Rabies Vaccine Product Portfolio
  30. 8.5.5 Prcmise Recent Developments
  31. 8.6 VACN
  32. 8.6.1 VACN Company Information
  33. 8.6.2 VACN Business Overview
  34. 8.6.3 VACN Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 VACN Rabies Vaccine Product Portfolio
  36. 8.6.5 VACN Recent Developments
  37. 8.7 Changsheng
  38. 8.7.1 Changsheng Company Information
  39. 8.7.2 Changsheng Business Overview
  40. 8.7.3 Changsheng Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Changsheng Rabies Vaccine Product Portfolio
  42. 8.7.5 Changsheng Recent Developments
  43. 8.8 BCHT
  44. 8.8.1 BCHT Company Information
  45. 8.8.2 BCHT Business Overview
  46. 8.8.3 BCHT Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 BCHT Rabies Vaccine Product Portfolio
  48. 8.8.5 BCHT Recent Developments
  49. 8.9 Hissen
  50. 8.9.1 Hissen Company Information
  51. 8.9.2 Hissen Business Overview
  52. 8.9.3 Hissen Rabies Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hissen Rabies Vaccine Product Portfolio
  54. 8.9.5 Hissen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rabies Vaccine Value Chain Analysis
  2. 9.1.1 Rabies Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rabies Vaccine Production Mode & Process
  6. 9.2 Rabies Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rabies Vaccine Distributors
  9. 9.2.3 Rabies Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst